Ujjivan Financial Services Ltd IPO Message Board (Page 47)

i applied single lot 5 app. Waiting for qib to come hoping for the best

ujjivan expected NII subscription 80-90x. My guess is that it will be closer to 100x. GMP right now 48-50. But listing expected at a premium of 70-90.

what is removed?? :D

Fake....eagleEYE...

costak price 900

sorry 900

gmp 47-49 in bhavnagar and costak 9000

Ujjivan IPO

Subscription:
QIB: 1.09x
NII: 29.23x
RII: 2.87x
Overall: 8.01x

No. of application (approx).: ~4,84,500
No.times of Applicationwise : 2.31x

Still do not see the demand as was anticipated. Septa, Eagleye: Do you still believe the market expectations on over subscription figures as mentioned earlier will still be met? Or is there any scaling down on the expectations. Kindly update, I am waiting for your response to apply.

ujjivan has to open 100 branches and that to in area or place where nationalised banks do not have branch

Thanks Eagleye,

I applied based on your response and now see much higher over subscription figures. Now waiting for allotment :)

Ujjivan total 4.5✖ subscribe

Subscription figures are not showing at NSE site

At what time does retail subscription ends.

plz septaji why have you excluded me.

plz septaji why have you excluded me.

NII MORE THAN 13 TIMES

Ujjivan IPO

Subscription:
QIB: 1.06x
NII: 3.58x
RII: 2.73x
Overall: 2.43x

No. of application (approx).: ~4,61,000+
No.times of Applicationwise : 2.19x

Eagleye ji,
Kindly clarify, Why you are saying to apply only one lot?
What is current GMP?

POOR subscription of QIB till now at 1 pm only 1.06 times but already applied in this ipo

RESPECTED EAGLEYE JI KINDLY UPDATE THE CURRENT GMP MY BROKER SAYING THIS INE GOING ON 42-44

KINDLY MARK THE AUTHENTICATION THE CURRENT PREMIUM

NSE

https://www1.nseindia.com/marketinfo/ipochart/ipochart.jsp?issue=UJJIVANCUMUEQ&ir=I&cn=C&sd=D&cnlink=N

Do do egaleye kaise hogye
Ek egaleye aue dusra egale Eye

nse se ipo remove kar diya ha ujjivan ka ?

Fake....is removed

In the case of Ujjivan IPO

for Retail applicants the correct strategy is to ...

Apply only 1 lot per application

Dear Eagleye,

How it may be best to apply for 1 lot per appln? the issue is oversubscribed > 1.86 times application wise and > 2.51 times shares wise for RII so may be approx same time basis shares and application for Retail investors.

which means most people have applied for 1 lot per appln and thus the chances are every third applicant may only get one lot !! in that case will it not increase chances of getting one let if some one applies for 3 lots per appln?

will appreciate your guidance in understanding above better as i am gonna put in my applications shortly now. Thanks

Ujjivan IPO

Subscription:
QIB: 1.06x
NII: 2.80x
RII: 2.51x
Overall: 2.16x

No. of application (approx).: ~390500
No.times of Applicationwise : 1.86x

THANK YOU......

Eagle Eye / Septa Sir,

quick question for you both experts, I am considering for the Ujjivan IPO uptil now application wise the ipo seem to have got subscribed by > 1.6 times so the chances are most applicants may end up getting just one lot.. correct? and thus it may make sense to not to apply for many lots per application .. to increase my chances to get max possible shares.. i will apply from three accounts.. can you suggest how many lots to apply from each appln? i am thinking of 3-4 lots per appln. will greatly appreciate your prompt reply.

PS - I know you can only guide basis probability and actual allotment gonna be dependent on sheer luck coz they select basis lottery !!

Once issue is oversubscribed at application level single lot multiple application in name of family and friends is only strategy

Many brokerages have given a ''subscribe'' rating on the issue, saying the IPO valuation looks reasonable and the company has potential to deliver strong growth and return on assets, even after its conversion into a small finance bank.

Ujjivan is well placed to tap the opportunities as it has a sound management team with extensive experience in the banking and financial services space.

"Valuations, per se, are comforting us compared with other listed players."